Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Fill out the form to reach out to our staff and we will get back to you asap!
The main GLP-1 agonist names in India include semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro), liraglutide (Victoza, Saxenda, Lirafit), dulaglutide (Trulicity), and exenatide (Byetta)
Seven additional Phase 3 TRIUMPH trials are expected to report results throughout 2026, covering obesity, type 2 diabetes, sleep apnea, chronic low back pain, and metabolic liver disease (ClinicalTrials.gov)
The role of GLP-1s in employee health According to the Employee Benefits Research Institute (EBRI), 55% of employers cover GLP-1s for diabetes and 36% for weight loss, a sharp increase from prior years
South Korea's National Health Insurance Service has expanded GLP-1 reimbursement conditions, sustaining growing prescription volumes in a market with high diabetes awareness and strong specialist prescribing culture
& Yankner, B
US$ 20.22
US$ 23.23
US$ 22.22
US$ 24.35
US$ 21.79
US$ 27.28
US$ 24.93
